ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE (abacavir , lamivudine and zidovudine) by Lupin Ltd. is nucleoside reverse transcriptase inhibitors [moa]. Approved for combination with other antiretroviral agents for the treatment of hiv-1 infection, combination with other antiretrovirals, alone for the treatment of human immunodeficiency virus type 1 (hiv-1) infection. First approved in 2013.
Drug data last refreshed 2h ago
Nucleoside Reverse Transcriptase Inhibitors
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Worked on ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE at Lupin Ltd.? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.